Kymera Therapeutics KYMR

$ 40.17 2.62%

Quarterly report 2024-Q3
added 10-31-2024

Kymera Therapeutics Financial Statements 2011-2024 | KYMR

Annual Financial Statements Kymera Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.33 B	1.78 B	2.02 B	1.07 B	-	-	-	-	-	-	-	-	-
Shares	58.4 M	53.9 M	48 M	17.3 M	-	-	-	-	-	-	-	-	-
Historical Prices	40	33	42	62	-	-	-	-	-	-	-	-	-
Net Income	-147 M	-155 M	-100 M	-45.6 M	-41.2 M	-21.5 M	-	-	-	-	-	-	-
Revenue	78.6 M	46.8 M	72.8 M	34 M	2.93 M	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-166 M	-161 M	-101 M	-46.3 M	-42.2 M	-	-	-	-	-	-	-	-
Interest Expense	18.6 M	6.45 M	313 K	711 K	959 K	-	-	-	-	-	-	-	-
EBITDA	-162 M	-158 M	-98.1 M	-44.5 M	-41.4 M	-21.2 M	-	-	-	-	-	-	-
Operating Expenses	244 M	208 M	173 M	80.3 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	55 M	43.8 M	36.3 M	18.2 M	7.98 M	3.77 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Kymera Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	76.1 M	73.1 M	70.8 M	55.4 M	58.4 M	58.3 M	58.2 M	55 M	54.5 M	51.8 M	51.7 M	51.5 M	50.7 M	45.1 M	44.6 M	44.5 M	20.7 M	2 M	1.95 M	1.93 M	1.75 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-62.5 M	-42.1 M	-48.6 M	-	-52.9 M	-38.8 M	-40.9 M	-	-43 M	-40.3 M	-36.7 M	-	-28.6 M	-24.7 M	-13.1 M	-	-7.99 M	-14 M	-10.9 M	-	-11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	3.74 M	25.6 M	10.3 M	-	4.73 M	16.5 M	9.47 M	-	9.55 M	11.5 M	9.62 M	-	20.3 M	18.5 M	18.7 M	-	14.5 M	3.29 M	3.43 M	-	950 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-72.1 M	-50.9 M	-57.8 M	-	-57.5 M	-43.4 M	-45.3 M	-	-44.9 M	-40.8 M	-36.9 M	-	-28.6 M	-24.7 M	-13.2 M	-	-8.08 M	-14.2 M	-11.2 M	-	-11.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	9.64 M	8.86 M	9.27 M	-	4.64 M	4.58 M	4.4 M	-	1.88 M	553 K	249 K	-	55 K	70 K	94 K	-	97 K	203 K	315 K	-	441 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-70.1 M	-49 M	-56.4 M	-	-56.6 M	-42.5 M	-44.4 M	-	-44.1 M	-40.1 M	-36.2 M	-	-26.9 M	-23.7 M	-12.7 M	-	-6.82 M	-13.4 M	-10.9 M	-	-11.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	75.9 M	76.6 M	68.1 M	-	62.2 M	59.9 M	54.8 M	-	54.4 M	52.3 M	46.6 M	-	49 M	43.2 M	31.9 M	-	22.6 M	17.5 M	14.7 M	-	12.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	15.5 M	17.4 M	14.4 M	-	14.1 M	14.1 M	12.6 M	-	10.6 M	11 M	10.6 M	-	10.7 M	8.03 M	5.91 M	-	6.84 M	3.66 M	2.56 M	-	1.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency